Viemed Healthcare EBIT

The latest EBIT for VMD is $23M as of June 2026. That compares with $21M in the prior-year period — up 12.5% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside Viemed Healthcare's historical trend and sector peers before judging valuation or financial health.

Over the past year, VMD's EBIT moved from $21M to $23M — a 12.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Viemed Healthcare's operating scale or balance-sheet position.

Against Healthcare companies, VMD currently prints $23M for EBIT, while the sector average sits near $22B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at Viemed Healthcare's growth, margins, and balance sheet.

A EBIT figure of $23M for VMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.

After noting VMD's EBIT ($23M), review year-over-year change from $21M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.